These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4326035)

  • 1. Activation of the carcinogen, N-hydroxy-2-fluorenylbenzene-sulfonamide, by desulfonylation to N-2-fluorenylhydroxylamine in vivo.
    Malejka-Giganti D; Gutmann HR; Rydell RE; Yost Y
    Cancer Res; 1971 Jun; 31(6):778-88. PubMed ID: 4326035
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the effect of the carcinogen N-hydroxy-N-2-fluorenylacetamide in infant and weanling rats.
    Weisburger JH; Klein M; Weisburger EK; Glass RM; Woodard G; Cronin MT
    J Natl Cancer Inst; 1970 Jul; 45(1):29-35. PubMed ID: 4317737
    [No Abstract]   [Full Text] [Related]  

  • 3. On the correlation between the hepatocarcinogenicity of the carcinogen, N-2-fluorenylacetamide, and its metabolic activation by the rat.
    Gutmann HR; Malejka-Giganti D; Barry EJ; Rydell RE
    Cancer Res; 1972 Jul; 32(7):1554-61. PubMed ID: 4337834
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of pituitary hormones and prefeeding N-hydroxy-N-2-fluorenylacetamide on the metabolism of this carcinogen and on physiologic parameters.
    Shirasu Y; Grantham PH; Yamamoto RS; Weisburger JH
    Cancer Res; 1966 Apr; 26(4):600-6. PubMed ID: 4287110
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of p-hydroxyacetanilide on liver cancer induction by N hydroxy-N-2-fluorenylacetamide.
    Yamamoto RS; Williams GM; Richardson HL; Weisburger EK; Weisburger JH
    Cancer Res; 1973 Mar; 33(3):454-7. PubMed ID: 4347712
    [No Abstract]   [Full Text] [Related]  

  • 6. Alteration of hepatocytes by subcarcinogenic exposure to n-2-fluorenylacetamide.
    Becker FF
    Cancer Res; 1975 Jul; 35(7):1734-6. PubMed ID: 165882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the carcinogenicity of the glucuronides of N-hydroxy-2-acetylaminofluorene and N-2-fluorenylhydroxylamine in the rat.
    Irving CC; Wiseman R
    Cancer Res; 1971 Nov; 31(11):1645-8. PubMed ID: 5121667
    [No Abstract]   [Full Text] [Related]  

  • 8. The cellular analysis of liver carcinogenesis. V. Ultrastructural alterations within hepatocellular carcinoma induced by ethionine.
    Merkow LP; Epstein SM; Slifkin M; Farber E; Pardo M
    Lab Invest; 1972 Mar; 26(3):300-5. PubMed ID: 4335732
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of postnecrotic cirrhosis on aflatoxin carcinogenesis in rats.
    Sun SC; Wei RD; Schaeffer BT
    Lab Invest; 1971 May; 24(5):368-72. PubMed ID: 4326522
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of trypan blue on hepatocarcinogenesis in rats given ethionine or N-2-fluorenylacetamide.
    Ito N; Farber E
    J Natl Cancer Inst; 1966 Dec; 37(6):775-85. PubMed ID: 4289069
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolism of continuously fed 14C-labeled N-hydroxy-N-2-fluorenylacetamide at various intervals: effect of pituitary hormones.
    Shirasu Y; Grantham PH; Weisburger EK; Weisburger JH
    Cancer Res; 1967 May; 27(5):865-72. PubMed ID: 4290554
    [No Abstract]   [Full Text] [Related]  

  • 12. Chromosome patterns in rat hepatocytes during N-2-fluorenylacetamide carcinogenesis.
    Becker FF; Fox RA; Klein KM; Wolman SR
    J Natl Cancer Inst; 1971 Jun; 46(6):1261-9. PubMed ID: 4325934
    [No Abstract]   [Full Text] [Related]  

  • 13. The carcinogenicity of the o-methoxy derivatives of N-2-fluorenylacetamide and of related compounds in the rat.
    Gutmann HR; Galitski SB; Foley WA
    Cancer Res; 1968 Feb; 28(2):234-44. PubMed ID: 5641517
    [No Abstract]   [Full Text] [Related]  

  • 14. Localization of alpha-fetoprotein by immunofluorescence in hyperplastic nodules during hepatocarcinogenesis induced by 2-acetylaminofluorene.
    Okita K; Gruenstein M; Klaiber M; Farber E
    Cancer Res; 1974 Oct; 34(10):2758-63. PubMed ID: 4370173
    [No Abstract]   [Full Text] [Related]  

  • 15. The cellular analysis of liver carcinogenesis. VI. Growth and ultrastructural characteristics of n-2-fluorenylacetamide hyperplastic liver nodule cells grown in vitro.
    Slifkin M; Merkow LP; Epstein SM; Pardo M
    Arch Pathol; 1972 Jul; 94(1):1-10. PubMed ID: 4338214
    [No Abstract]   [Full Text] [Related]  

  • 16. Cell loss and proliferation induced by N-2-fluorenylacetamide in the rat liver in relation to hepatoma induction.
    Albert RE; Burns FJ; Bilger L; Gardner D; Troll W
    Cancer Res; 1972 Oct; 32(10):2172-7. PubMed ID: 4343011
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatic carcinogenesis in thyroidectomized rats: apparent blockade at the stage of initiation.
    Goodall CM
    Cancer Res; 1966 Sep; 26(9):1880-3. PubMed ID: 4288670
    [No Abstract]   [Full Text] [Related]  

  • 18. Accelerated induction of hepatoma in rats fed N,N'2,7-fluorenylenebisacetamide by x-irradiation to the target area.
    Nagayo T; Ito M; Yamada S
    Gan; 1970 Feb; 61(1):81-3. PubMed ID: 4315328
    [No Abstract]   [Full Text] [Related]  

  • 19. Carcinogenesis in rats by aflatoxins B1, G1, and B2.
    Butler WH; Greenblatt M; Lijinsky W
    Cancer Res; 1969 Dec; 29(12):2206-11. PubMed ID: 4318833
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of fatty acids (linolenic, linoleic and oleic) on the growth of 2-acetylaminofluorene-induced tumors in rats].
    Vysheslavova MIa
    Vestn Akad Med Nauk SSSR; 1972; 27(2):22-7. PubMed ID: 4336546
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.